SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-171423
Filing Date
2022-06-10
Accepted
2022-06-10 06:05:03
Documents
9
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 6-K d319008d6k.htm 6-K 17964
2 EX-99.1 d319008dex991.htm EX-99.1 11963
3 GRAPHIC g319008ex99_1s1g1.jpg GRAPHIC 488301
4 GRAPHIC g319008ex99_1s2g1.jpg GRAPHIC 646687
5 GRAPHIC g319008ex99_1s3g1.jpg GRAPHIC 334371
6 GRAPHIC g319008ex99_1s4g1.jpg GRAPHIC 264526
7 GRAPHIC g319008ex99_1s5g1.jpg GRAPHIC 274815
8 GRAPHIC g319008ex99_1s6g1.jpg GRAPHIC 314068
9 GRAPHIC g319008g53v61.jpg GRAPHIC 89182
  Complete submission text file 0001193125-22-171423.txt   3353985
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40212 | Film No.: 221007563
SIC: 2834 Pharmaceutical Preparations